China Pharma Holdings (CPHI) news
Recent news
ChinaRes Pharma discloseable transaction proposed purchase of Lier Chemical
AInvest Wire · Jul 29, 2026China Pharma Holdings, Inc. announces closing of $5.0 million registered direct offering
China Pharma Holdings, Inc. (NYSE American: CPHI) has completed a $5.0 million registered direct offering, priced at $2.00 per share, with the offering expected to close on July 23, 2026. The company issued 2.5 million shares of common stock, with gross proceeds before deducting placement agent…
AInvest Wire · Jul 23, 2026China Pharma announces pricing of $5 million registered direct offering
China Pharma Holding Inc. (NYSE: CPH) has announced the pricing of a $5 million registered direct offering, with the transaction expected to close on or about July 25, 2026, subject to customary closing conditions [1]. The company issued 1.25 million shares of its common stock at a price of $4.00…
AInvest Wire · Jul 22, 2026Hengrui Pharma: agreements with Bristol-Myers Squibb
Bristol-Myers Squibb (BMS) has announced the sale of its controlling 60% stake in its historic U.S.-China pharmaceutical joint venture, Sino-American Shanghai Squibb Pharmaceuticals (SASS), marking a strategic shift in its manufacturing and operational focus in China. The joint venture, established…
AInvest Wire · May 12, 2026China Pharma Holdings announced that its Dry Eye Disease (DED) therapeutic device has passed third-party testing and is preparing to apply for market launch to NMPA of China.
AInvest Wire · Nov 30, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.